Doctor-delivered intimate and vaginal radiofrequency
Intimate & Vaginal Radiofrequency Treatment
Private assessment and doctor-delivered radiofrequency treatment for selected vulval and vaginal concerns. Suitability, treatment areas, medical-device status, evidence limits, risks, alternatives, course planning and fees are discussed before treatment.
- CQC registered Regulated and inspected
- 4.8 / 5 From 3,500+ reviews
- Assessment-led Suitability before treatment
Your first step
Private intimate radiofrequency treatment starts with a doctor consultation
Women researching vaginal radiofrequency may be concerned about dryness, discomfort, reduced tissue quality, laxity or changes after childbirth or menopause. Similar symptoms can also arise from infection, vulval skin disease, pelvic-floor dysfunction, hormonal change or another condition.
That is why assessment comes first. A doctor reviews the concern, examines where clinically appropriate, explains established options and considers radiofrequency only when the proposed device, treatment area and available evidence fit the individual plan.
Educational only. Not a diagnosis or medical advice. Suitability is confirmed after consultation and assessment. Results vary. Intimate or vaginal radiofrequency is not a cure, is not suitable for everyone and should not replace established first-line care when that care is appropriate. Device-specific contraindications and risks must be reviewed before treatment.
Watch patient stories, case studies and media features
These WHC patient stories, case discussions and selected media features provide wider clinic context. They are not all about radiofrequency treatment, and individual experiences do not predict RF suitability or outcomes.
What is intimate and vaginal radiofrequency treatment?
Radiofrequency treatment uses controlled electromagnetic energy to generate heat within selected tissues. In intimate health, specially designed applicators may be used externally on the vulva or labial area and/or internally within the vagina, depending on the device, manufacturer instructions and agreed clinical plan.
The intended controlled thermal response is different from laser treatment, injectable treatments and surgery. “Intimate RF,” “vaginal RF” and “radiofrequency vaginal treatment” are commonly used search terms, but they do not describe one universal device, temperature, protocol or treatment indication.
A practical definition
Intimate radiofrequency is a non-surgical energy-based procedure in which a device delivers controlled RF energy to a selected vulval or vaginal area. The clinician follows the device instructions and monitors treatment parameters; the procedure should not be reduced to the marketing phrase “vaginal tightening”.
Vaginal, vulval or intimate RF?
The vagina is the internal canal; the vulva is the external intimate area. WHC may consider all clinically appropriate areas, but not every applicator or RF device is intended for every area. Examination findings, device documentation and the agreed objective determine what is treated.
A discreet subject
Women may ask about RF because of dryness, discomfort, tissue change, laxity concerns, menopause, childbirth or interest in a non-hormonal procedure. The conversation should be clinical, private and respectful—without implying that normal vulval or vaginal variation requires treatment.
Radiofrequency is not the same as laser
Radiofrequency uses electrical energy to generate controlled tissue heating. CO₂ and erbium lasers use light energy and different tissue interactions. Devices also vary in whether energy is monopolar, bipolar or multipolar, whether treatment is internal or external, and how temperature or energy delivery is controlled. Results from one technology cannot automatically be transferred to another.
Read more: our technology-neutral approach+
WHC does not promote a manufacturer or imply a commercial affiliation. We use medical CE-marked equipment and review the applicable device documentation, traceability, intended purpose, treatment area and UK regulatory requirements before use.
A CE mark is a conformity mark for the device and its stated intended purpose. It should not be presented as proof that radiofrequency is effective for every intimate symptom or suitable for every woman.
Who may consider intimate radiofrequency treatment?
Vaginal radiofrequency may be discussed with selected women exploring a non-surgical, non-hormonal energy-based option for particular vulval or vaginal concerns—but only after clinical assessment.
Women after childbirth
Some women notice laxity, dryness, reduced comfort or tissue change after pregnancy and birth. RF may be discussed after appropriate recovery, but postpartum concerns can also involve prolapse, scar tissue, pelvic-floor injury, breastfeeding-related hormone change or pain and may need another pathway.
Perimenopausal and menopausal women
Lower oestrogen levels can affect the vulva, vagina, bladder and urethra—often described as genitourinary syndrome of menopause (GSM). RF is not a replacement for established first-line care, but may be discussed as an additional or alternative procedure after proper review.
Women exploring non-hormonal support
Some women are interested in non-hormonal options because of personal preference, previous experience, contraindications or concerns about hormones. This should be discussed medically, especially if symptoms may be better managed with established treatments.
Women concerned about laxity or tissue change
Some women describe reduced support, a feeling of looseness, air trapping, dryness or a change in comfort. RF may be considered only when the concern and examination findings fit the proposed treatment; pelvic-floor dysfunction, prolapse and other causes must not be missed.
Read more: why GSM and menopause symptoms need proper first-line care+
GSM can involve dryness, irritation, soreness, urinary symptoms, recurrent discomfort and painful intimacy. NICE guidance includes options such as vaginal oestrogen, moisturisers and lubricants, with other menopause treatments considered according to the individual.
Vaginal RF should sit within a wider clinical conversation. It should not replace diagnosis or established care where that care is appropriate.
Suitability for private vaginal RF treatment
Women enquiring about intimate or vaginal radiofrequency often describe one or more of the following concerns.
These symptoms do not automatically mean RF is suitable. Similar concerns may be caused by hormonal change, vulval dermatoses, infection, inflammation, pelvic-floor dysfunction, prolapse, medication, pain conditions or other medical issues.
Who may not be suitable?
Intimate or vaginal RF may not be appropriate, or may need to be delayed, if there is:
This is not a complete contraindication list. The final decision follows medical history, examination, the device instructions for use and clinical judgement.
Why assessment matters
Dryness, pain, urinary symptoms, irritation, laxity or tissue change can have different causes. RF should not be used to bypass diagnosis, menopause care, vulval assessment, pelvic-floor review or investigation of unexplained symptoms.
Realistic expectations
RF may be considered for selected concerns, but it is not a cure for GSM, atrophy, pain, laxity, sexual dysfunction, prolapse or urinary incontinence. Response varies and some women may notice little or no meaningful change.
Risks and limitations
As with any energy-based intimate treatment, risks and limitations must be discussed before treatment.
Read more: why “non-hormonal” does not mean “better for everyone”+
Some women prefer non-hormonal options, and that preference should be respected. However, if symptoms are caused by oestrogen deficiency or GSM, established first-line treatments may be more appropriate, better evidenced or more cost-effective. The right plan depends on the woman, the symptoms and the clinical findings.
Why choose private vaginal radiofrequency treatment at WHC?
Women comparing private treatment providers usually want qualified delivery, clear prices, suitable medical equipment, honest evidence and a plan based on assessment rather than a device-led sales pathway.
Functional and comfort reasons
Women may ask because dryness, laxity concerns, air trapping, sensitivity or discomfort has affected daily life, exercise, clothing, intimacy or confidence.
Life-stage reasons
Menopause, childbirth, breastfeeding, ageing, hormonal shifts and some medical treatments can change vulval and vaginal tissue. The treatment discussion should be shaped by the cause.
Emotional reasons
Some women feel embarrassed, dismissed or unsure how to raise intimate symptoms. A respectful consultation can help clarify what is happening and what may genuinely help.
Tissue-quality goals
RF is being studied for selected vulvovaginal concerns, including GSM-related symptoms and perceived laxity. The quality and applicability of evidence differ by device, indication and outcome measure.
Controlled thermal response
RF devices convert electromagnetic energy into controlled heat within tissue. Proposed remodelling responses are biologically plausible, but the clinical effect and duration cannot be assumed for every device or concern.
Confidence through clarity
Sometimes the most important step is understanding the cause of symptoms and knowing which options are sensible, rather than assuming one procedure is the answer.
Balanced, evidence-aware care
We use cautious language because findings from a specific RF device, protocol and study group cannot be generalised to every technology, anatomical area or woman. That honesty is part of responsible doctor-delivered care.
What women may be hoping for
Women may hope for improved comfort, support with dryness, better perceived tissue quality, less laxity or additional help alongside menopause or pelvic-floor care. These are goals for discussion, not promised outcomes.
Results vary from person to person. Suitability is always confirmed after consultation and assessment.
How private intimate radiofrequency treatment works
The procedure is non-surgical, but the clinical decision still requires care. The aim is to match the RF device, applicator, anatomical area and treatment parameters to the woman’s symptoms, medical context and realistic goals.
1. Doctor consultation
We review symptoms, medical history, menopause or postpartum context, previous surgery, implanted devices, current treatments, expectations and whether established first-line care has been considered.
2. Assessment and planning
The plan may consider external vulval tissue, labial areas, the vestibule or introitus, and the vaginal canal where appropriate. The final area, applicator, settings and number of sessions depend on examination, device documentation and clinical judgement.
3. Treatment session
The area is prepared and the doctor applies the appropriate RF applicator. Controlled energy is delivered according to the device protocol while treatment parameters and the woman’s comfort are monitored. Appointment length depends on the areas and plan.
4. Aftercare and review
You receive written aftercare, what to expect, what to avoid temporarily, when to contact the clinic, and whether further sessions may be appropriate.
How radiofrequency energy interacts with tissue
Radiofrequency energy causes resistance within tissue and generates controlled heat. Devices differ in energy delivery, electrode configuration, applicator design, temperature feedback and intended anatomical use. The proposed response includes short-term tissue effects and longer remodelling, but a mechanism does not guarantee a clinical outcome.
Energy delivery
An RF generator sends electromagnetic energy through the treatment applicator. Tissue resistance converts that energy into heat within the selected area.
Temperature control
Treatment is delivered within the parameters specified for the medical device. Monitoring and technique are important because excessive heat can injure tissue.
Device and area matter
External and internal applicators are not interchangeable. The doctor must match the medical device’s intended purpose, instructions and treatment parameters to the proposed vulval or vaginal area.
Response over time
Some women may notice changes during or after a course, while others may not. RF does not guarantee tightening, lubrication, continence, sexual improvement or permanent tissue regeneration.
Plain-English way to think about it
Vaginal RF uses a medical device to warm selected tissue in a controlled way. It is not surgery and does not remove tissue, but it is still an energy-based medical procedure with limitations and risks. It should not be presented as a way to “reverse ageing” or restore a vagina to a supposed ideal.
How does vaginal radiofrequency compare with other treatments?
Radiofrequency, CO₂ laser, PRP, filler, skin boosters, polynucleotides and exosomes are not interchangeable. The best direction depends on diagnosis, symptoms, anatomy, medical history, evidence, expectations and suitability.
Radiofrequency vs O-Shot / PRP
RF uses controlled thermal energy. PRP uses platelet-rich plasma prepared from the woman’s blood and delivered by injection. Their mechanisms, evidence, contraindications, risks and objectives differ. Read about O-Shot-style intimate and vaginal PRP.
Radiofrequency vs G-Shot / filler
G-Shot-style and intimate filler procedures place hyaluronic-acid filler for a focal volume or projection objective. RF does not inject filler or deliberately add volume. Compare G-Shot and intimate vaginal filler.
Radiofrequency vs vaginal laser
Both are energy-based treatments, but RF uses electromagnetic energy and laser uses light energy. Tissue interaction, applicators, protocols, evidence and risks differ. Neither is universally better. Explore Nu‑V CO₂ intimate laser treatment.
Radiofrequency vs injectable regenerative treatments
Polynucleotides, exosomes and skin boosters place materials into selected tissue; RF uses energy and no injectable treatment material. Evidence and regulatory considerations differ. Compare intimate and vaginal polynucleotides, intimate and vaginal exosomes or vulval and vaginal skin boosters.
Where vaginal rejuvenation fits
“Vaginal rejuvenation” is a broad consumer term covering different symptoms, goals and procedures. RF is one energy-based option within that wider discussion—not a diagnosis, a universal treatment or a guarantee of rejuvenation.
Read about vaginal rejuvenationRecovery and aftercare
Many women return to gentle normal activities after treatment, but temporary warmth, redness, tenderness, swelling, discharge, spotting or irritation can occur.
You will receive written aftercare, including expected symptoms, warning signs and when to contact the clinic.
You may be advised to avoid intercourse, tampons, swimming, hot baths, saunas, harsh products and strenuous exercise for a short period.
Exact restrictions depend on the area treated, device protocol and individual clinical plan.
Course and follow-up
Your vaginal radiofrequency treatment course
A course of four is common at WHC, but planning and response are individual rather than one-size-fits-all.
When might changes be noticed?
Published RF studies assess outcomes at different time points, often after completing a course. Some women may notice changes during the treatment pathway; others may notice little or no meaningful improvement. No individual result can be predicted.
How many sessions are needed?
WHC commonly plans a course of four sessions, but this varies according to assessment, device protocol, treatment area, clinical response and individual need. The optimal number of RF sessions is not established across all devices and indications.
Is maintenance needed?
Effects should not be presented as permanent. The best maintenance schedule remains uncertain. Further treatment should be discussed only after review, where benefit has been reported, suitability remains and the device guidance supports the plan.
Intimate and vaginal radiofrequency before and after
These before-and-after images are artistic impressions for illustration only. They are not clinical photographs and do not show a guaranteed anatomical, vaginal, tightening, tissue-quality, comfort, urinary or sexual response. Outcomes vary according to the concern, RF technology, treatment area, tissue quality, hormonal background, treatment plan and individual response.
Request a confidential consultationIllustrative before & after
The slider is an artistic representation, not a clinical photograph or promise of outcome. Suitability, evidence limits, risks and realistic expectations are discussed during consultation.
Doctor-delivered intimate radiofrequency treatment at WHC
Intimate and vaginal radiofrequency treatment is delivered by doctors at WHC. We keep the discussion private, explain the device, evidence and limitations, and help women understand whether RF, established care, another treatment or no procedure is the most appropriate direction.
Women-friendly, respectful care
We understand that many women feel uncertain, embarrassed or dismissed when raising intimate concerns. The conversation should feel calm, discreet and medically grounded.
Clear and realistic explanations
We explain what radiofrequency is intended to do, what it cannot promise, where evidence is mixed or limited, and when another pathway may be better.
Why women choose WHC
Doctor-delivered, women-centred, private and evidence-aware care with clarity rather than pressure.
Part of a broader vaginal wellness pathway
Vaginal RF may sit alongside broader vaginal wellness, menopause care, pelvic-floor support, conservative symptom management or another planned treatment, depending on the clinical picture.
Private vaginal radiofrequency treatment prices
Private intimate and vaginal radiofrequency treatment
We advise a doctor face-to-face consultation before treatment so that symptoms, suitability, expectations, alternatives and the treatment plan can be properly reviewed.
Doctor face-to-face consultation
Recommended before treatment so the cause of symptoms, suitability, risks and alternatives can be properly assessed.
Doctor consultation
Single session
A single doctor-delivered intimate or vaginal radiofrequency treatment session, after suitability has been confirmed.
Per treatment session
Course of four
A course of four is commonly planned, but the number and interval of sessions may vary after assessment and review.
Course pricing
Why consultation comes first
The correct plan depends on whether RF is suitable at all, which areas are appropriate, whether established care or another treatment would be better, and whether a course is justified.
Course planning
A course of four is commonly offered, but the number and interval of sessions may vary according to the device protocol, area treated, clinical plan and response.
Clear published fees
Consultation is £150, a single treatment is £699 and a course of four is £2,300. Please check the pricing page before booking in case published fees change.
Experience
How women often want the experience to feel
Women considering intimate or vaginal RF often want privacy, honest explanations and a doctor who will not exaggerate outcomes.
We avoid claiming that RF reverses menopause, permanently tightens the vagina, cures dryness, fixes painful sex or guarantees urinary or sexual improvement. Instead, we explain the treatment, evidence and risks so women can make an informed decision.
Feeling listened to
A good treatment journey begins with understanding the concern, not rushing to the procedure.
Clear explanations
We explain treatment mechanism, risks, limitations, evidence, costs and alternatives in plain language.
No pressure
If vaginal radiofrequency is not suitable, we will explain why and discuss a more appropriate direction.
Private treatment pathway
From consultation to vaginal RF treatment
Every woman’s plan is different, but private treatment follows a clear assessment, consent, delivery and review pathway.
1. She notices a change
It may be dryness, discomfort, laxity, air trapping, menopause-related change or post-childbirth change.
2. She researches options
She may find radiofrequency, laser, pelvic-floor treatment, menopause care or injectable treatments and feel unsure what is appropriate.
3. She books consultation
We advise a face-to-face doctor consultation so the concern can be properly understood before treatment is considered.
4. She has a proper review
We assess symptoms, anatomy, menopause context, postpartum history, first-line options, risks and expectations.
5. She receives a tailored plan
That may include RF, a course of four, first-line GSM care, pelvic-floor support, laser, another treatment or no procedure.
Intimate and vaginal radiofrequency treatment FAQs
Practical answers about private vaginal radiofrequency treatment at WHC, including the procedure, doctor delivery, treatment areas, course, prices, aftercare, evidence and risks.
It is a non-surgical energy-based procedure using a medical radiofrequency device. A suitable internal or external applicator delivers controlled RF energy to the agreed vulval or vaginal area. Tissue resistance converts the energy into heat. Devices, parameters and intended uses differ, so vaginal RF is not one standardised treatment.
Yes. WHC offers private consultation and, where suitable, doctor-delivered intimate and vaginal radiofrequency treatment. Consultation is required before treatment so the concern, anatomy, alternatives, risks, proposed areas and course can be reviewed.
Doctors deliver the treatment at WHC. The treatment plan is also assessment-led, with device suitability, medical history, examination findings and consent reviewed before RF is performed.
WHC does not promote one manufacturer or commercial affiliation. We use medical CE-marked equipment selected according to the intended treatment area, applicable documentation, UK requirements and individual plan. The proposed device and treatment approach should be explained before consent.
CE marking shows that the manufacturer has followed the applicable conformity route for the device and its stated intended purpose. CE-marked medical devices may be accepted on the Great Britain market under current UK arrangements when the relevant requirements are met. A CE mark does not prove that every advertised benefit is established or that the device is suitable for every woman or anatomical area.
WHC may consider all clinically appropriate external and internal areas, including selected vulval, labial, vestibular, introitus and vaginal tissues. The final area depends on the concern, examination, device applicator, manufacturer instructions and clinical judgement. Not every device or applicator is suitable for every area.
After the plan and consent are confirmed, the area is prepared and the doctor uses the appropriate internal and/or external RF applicator. Controlled energy is delivered according to the device protocol while treatment parameters and comfort are monitored. The exact appointment length depends on the areas treated and plan.
No. RF uses electromagnetic energy to generate controlled heat; CO₂ or erbium lasers use light energy and interact with tissue differently. Applicators, protocols, tissue effects, evidence and risks are not identical. Neither treatment should be presented as universally better.
No. Standard non-ablative vaginal RF does not involve surgical cutting, stitches or injection of filler, PRP, skin booster, polynucleotide or exosome material. It remains a medical energy-based procedure and is not risk-free.
Women commonly describe warmth and may experience pressure, sensitivity or discomfort. Experience varies by device, area, settings and individual sensitivity. WHC does not describe the procedure as universally painless; tell the doctor immediately if treatment feels excessively hot or painful.
Many women return to gentle normal activities after treatment. Temporary warmth, redness, tenderness, swelling, discharge, spotting or irritation can occur. You may be asked to avoid intercourse, tampons, swimming, hot baths, saunas, harsh products and strenuous exercise for a short period. Follow the written aftercare provided for your plan.
WHC commonly offers a course of four, but treatment varies from woman to woman. The number and spacing of sessions depend on assessment, the medical device protocol, treatment areas, response and clinical judgement. The optimal regimen is not established across all RF devices and indications.
The doctor face-to-face consultation is £150. A single radiofrequency treatment session is £699, and a course of four is £2,300. The course may vary after assessment. Check the current WHC pricing page before booking in case fees change.
Similar concerns can have different causes and may need menopause care, pelvic-floor treatment, investigation or another procedure. Consultation allows the doctor to review history, examine where appropriate, identify red flags, explain alternatives and decide whether RF and the proposed areas are suitable. Consultation does not guarantee treatment.
Outcomes vary and cannot be guaranteed. Published studies use different devices, protocols and outcomes, with mixed findings. Some women report changes in comfort, dryness, perceived laxity or sexual-function scores; others may notice little or no meaningful improvement. RF should not be presented as permanent rejuvenation.
No. “Radiofrequency vaginal tightening” is a common search and marketing phrase, but it is not a guaranteed result. RF does not surgically tighten the vagina, repair prolapse or strengthen pelvic-floor muscles. Perceived laxity needs assessment because the cause affects which treatment, if any, is appropriate.
It may be discussed with selected women, but it is not standard first-line treatment for genitourinary syndrome of menopause. NICE guidance includes vaginal oestrogen, moisturisers and lubricants, with other options considered according to individual circumstances. Do not stop prescribed treatment without medical advice.
RF has been studied for urinary symptoms, but evidence varies and it is not a substitute for continence assessment. NICE recommends supervised pelvic-floor muscle training as first-line treatment for stress or mixed urinary incontinence. Leakage may also require bladder, pelvic-floor, prolapse or specialist review.
RF may be discussed after appropriate postnatal recovery in selected women. Treatment is not a substitute for assessing pelvic-floor injury, prolapse, scar pain, infection, breastfeeding-related hormone change or other postpartum concerns. Timing and suitability are decided during consultation.
Potential effects include warmth, tenderness, redness, swelling, irritation, discharge or spotting. Infection, burns, blistering, scarring, altered sensation, pain during intercourse and persistent pain have also been reported with vaginal energy-based devices. The true long-term risk profile is not fully established.
Treatment may be unsuitable or delayed with pregnancy, recent childbirth, active genital or urinary infection, unexplained bleeding or pain, suspicious vulval or vaginal lesions, current pelvic malignancy, recent pelvic surgery, previous pelvic radiotherapy, certain implanted electrical devices or another device-specific contraindication. This is not a complete list; individual assessment and the device instructions govern suitability.
Sometimes, but only as a planned, staged pathway after assessment. RF may be considered alongside menopause care, pelvic-floor support, laser, PRP, skin boosters, polynucleotides or another treatment. Combination treatment is not automatically better, and the safest sequence and interval depend on the procedures and clinical plan.
Evidence is developing and mixed. Some randomised and comparative studies report improvements in selected outcomes, while a 2024 randomised trial found low-energy RF was not superior to gel and lacked statistical power. Studies differ in device, participants, comparator, course and follow-up. Long-term safety, durability and the optimal regimen remain uncertain.
Book private vaginal RF assessment
1. Request a £150 doctor consultation
2. Discuss the treatment and areas of concern
3. Review suitability, evidence, risks and alternatives
4. Confirm whether a single session or course is appropriate
5. Proceed only after informed consent
Treatment is private, assessment-led and doctor-delivered. Consultation does not guarantee that radiofrequency will be recommended or performed.
What should private vaginal RF patients know about the evidence?
Women comparing private vaginal radiofrequency providers should receive enough evidence information for informed consent. Results differ by device, indication, protocol and study design, and long-term certainty remains limited.
Findings are mixed
Some randomised and comparative studies report improvements in selected patient-reported outcomes. Other trials show no superiority for primary or secondary outcomes. A positive study for one device or group cannot establish a universal RF benefit.
Course planning is individual
WHC commonly offers a course of four, but professional consensus has not established one optimal number, interval or maintenance schedule for all vulvovaginal RF devices and indications. The clinical pathway may therefore vary.
Long-term certainty is limited
Short-term safety findings are generally more reassuring than the long-term evidence. Burns, scarring, pain, altered sensation and pain during intercourse have been reported with vaginal energy-based devices; the true incidence and long-term profile are uncertain.
WHC private-treatment position
We provide treatment only after doctor consultation and suitability assessment. Device conformity, intended use and traceability are checked, but regulatory marking is not used as an efficacy claim. A woman should understand the proposed areas, likely course, alternatives, fees, uncertainties and risks before deciding.
Research, professional guidance and UK device information+
- AUGS Clinical Consensus Statement, 2022 update — expert consensus on vaginal energy-based devices, evidence gaps, safety and treatment considerations.
- Joris et al., 2024 — randomised low-energy RF trial for GSM; RF was not superior to gel and the study lacked power.
- Chinthakanan et al., 2023 — randomised sham-controlled RF study for stress urinary incontinence with mixed objective and secondary findings.
- Pereira et al., 2024 — randomised comparison of pelvic-floor muscle training and radiofrequency for women reporting vaginal laxity.
- NICE NG23: Menopause — established management options for genitourinary symptoms associated with menopause.
- NICE QS77 — supervised pelvic-floor muscle training as first-line treatment for stress or mixed urinary incontinence.
- MHRA: regulating medical devices in the UK — current Great Britain requirements, MHRA registration and transitional acceptance of CE-marked medical devices.
Responsible treatment wording
Private treatment information should be clear enough to support a booking decision without promising a medical or emotional transformation.
We avoid saying
We prefer saying
WHC provides this as a distinct private intimate radiofrequency treatment. Detailed assessment pathways remain available for women whose main concern is vaginal laxity, dryness, GSM, painful sex or urinary symptoms.
Related Intimate Health Guides
Read expert women’s health articles
Explore our expert medical articles covering women’s health, menopause, intimate health, gynaecology, regenerative wellness and preventative care. These resources are written to help patients understand their options before booking a consultation.
No results found
Try a broader term or adjust your topic filters.
Still not sure where to start?
Browse the wider treatment pages or book a free consultation.
Browse our women’s health FAQs
Find clear answers to common questions about consultations, treatments, symptoms, preparation, aftercare, pricing and what to expect when visiting The Women’s Health Clinic. Use the FAQ bubbles below to continue exploring.
